As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.

By supporting and encouraging evidence-based access to gene therapy, payers and other segments of U.S. society will be positioned to benefit from future advancements and biopharmaceutical breakthrough...

Breaking down the challenges, therapies and costs associated with hemophilia.

As treatment for hemophilia evolves, data proves a good specialty pharmacy partner can help minimize waste and drive efficient practices.